Friday Mar 29, 2024
Search News
Capital
Nation
Politics
Issues
Global
Business
Sports
Health
Travel & Tourism
Science & Technology
Entertainment & Lifestyle
Gallery
Friday Mar 29, 2024
Capital
Nation
Politics
Issues
Global
Business
Sports
Health
Travel & Tourism
Science & Technology
Entertainment & Lifestyle
Gallery
Published by Nepalnews Pvt Ltd
Editor:
Raju Silwal
Information Department Registration No. 1505 / 076-77
Capital
Nation
Politics
Issues
Global
Business
Sports
Health
More
Travel & Tourism
Science & Technology
Entertainment & Lifestyle
Gallery
Hemophilia
$2.9 million gene therapy for severe hemophilia
Jul 1, 2023
U.S. officials on Thursday approved drugmaker BioMarin’s gene therapy for the most common form of hemophilia.
Hemophilia therapy gets FDA approval
Nov 23, 2022
US health regulators on Tuesday approved the first gene therapy for hemophilia.
People with hemophilia to be counted in upcoming census
Sep 25, 2021
The government is going to count people with hemophilia in the national census-2078 BS.
Recent News
16 minutes ago
Honoring Nepali security personnel Sherpa in Malaysia
41 minutes ago
Nepal could reap benefits from China's GDI: UML Vice-Chair Poudel
1 hour ago
Dept. of Mines and Geology issues license to 159 mines for excavation
2 hours ago
Speaker-led delegation returns home
2 hours ago
Economic empowerment main basis for women's empowerment: Prime Minister
Trending
TU forms committee to probe into missing answer sheets
Weather to improve from Sunday
Government fixes minimum support price of winter paddy
Irregularities in MDMS procurement: Charge sheet filed against 20, including two former chairs
Present coalition is not power-focused, Oli argues
Nepal's First Online News Portal
Published by Nepalnews Pvt Ltd
Editor:
Raju Silwal
Information Department Registration No. 1505 / 076-77
Contact
KMC-02, UttarDhoka,
Lazimpat, Nepal
Newsroom
+977–01–4445751 / 4445754
E-mail
[email protected]
[email protected]
Social Media
Facebook
Instagram
Twitter
Youtube
Exploration
About Us
Privacy Policy
Archive
Terms of Use
Disclaimer
© NepalNews. 2021 All rights reserved. | Nepal's First News Portal